I like Her-Vaxx a lot but agree, it should be sold. Firstly to concentrate cost and effort towards the CF33 applications and CAR-T and secondly to show the market that IMU is able to develop and sell their assets.
But I am sure in the event of selling any asset there will be a lot of different opinions at what price and Ts&Cs. In 2021 the expectations ranged from USD 500m to up to USD 1b. Not sure if those amounts can be achieved or exceeded in 2024 / 25. Time will tell.
GLTA
Ann: Half Yearly Report and Accounts, page-95
-
- There are more pages in this discussion • 49 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
-0.002(4.00%) |
Mkt cap ! $356.9M | |||
| Open | High | Low | Value | Volume |
| 5.0¢ | 5.0¢ | 4.7¢ | $2.298M | 47.86M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 1925982 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 3452098 | 12 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |